ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

Oncology Nursing Society Small Grants Available

July 19, 1996

FDA Seeks Consumers For Advisory Committees.

November 23, 2001